About N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide
N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide (PubChem CID 169188965) has the molecular formula C28H38N10O3
and a molecular weight of 562.68 g/mol. Its IUPAC name is N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide.
Molecular Properties
| Compound Name | N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide |
| PubChem CID | 169188965 |
| Molecular Formula | C28H38N10O3 |
| Molecular Weight | 562.68 g/mol |
| Exact Mass | 562.31 |
| IUPAC Name | N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide |
| SMILES | Cc1ccncc1C(=O)Nc1cc(-n2cc(C(=O)NC(N)CCN3CCOCC3)nn2)ccc1N1CCN(C)CC1 |
| InChI | InChI=1S/C28H38N10O3/c1-20-5-7-30-18-22(20)27(39)31-23-17-21(3-4-25(23)37-11-9-35(2)10-12-37)38-19-24(33-34-38)28(40)32-26(29)6-8-36-13-15-41-16-14-36/h3-5,7,17-19,26H,6,8-16,29H2,1-2H3,(H,31,39)(H,32,40) |
| InChIKey | ONKRQINGXZSVRA-UHFFFAOYSA-N |
| XLogP | 0.71 |
| TPSA | 146.77 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 41 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 562.68 |
| LogP ≤ 5 | 0.71 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 11 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Analyze N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide?
The IUPAC name of N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide (CID 169188965) is N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide.
What is the SMILES notation for N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide?
The canonical SMILES for N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide is Cc1ccncc1C(=O)Nc1cc(-n2cc(C(=O)NC(N)CCN3CCOCC3)nn2)ccc1N1CCN(C)CC1.
What is the InChIKey of N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide?
The InChIKey is ONKRQINGXZSVRA-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H38N10O3/c1-20-5-7-30-18-22(20)27(39)31-23-17-21(3-4-25(23)37-11-9-35(2)10-12-37)38-19-24(33-34-38)28(40)32-26(29)6-8-36-13-15-41-16-14-36/h3-5,7,17-19,26H,6,8-16,29H2,1-2H3,(H,31,39)(H,32,40).
What are the key properties of N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide?
N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide has a molecular weight of 562.68 g/mol, XLogP of 0.71, 9 rotatable bonds, 3 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[4-[(1-amino-3-morpholin-4-ylpropyl)carbamoyl]triazol-1-yl]-2-(4-methylpiperazin-1-yl)phenyl]-4-methylpyridine-3-carboxamide is sourced from PubChem (CID 169188965), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).